Zaleplon and Vesicare drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zaleplon (zaleplon) and Vesicare (solifenacin succinate). Common drug interactions include pain among females and cholecystitis chronic among males.
The phase IV clinical study analyzes what interactions people have when they take Zaleplon and Vesicare. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.
What is Zaleplon?
Zaleplon has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 1,935 Zaleplon users. Check the latest studies of Zaleplon.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,655 Vesicare users. Check the latest studies of Vesicare.
28 people who take Zaleplon and Vesicare together, and have interactions are studied.

What are the common drug interactions of Zaleplon and Vesicare, by gender? *:
female:
- Pain
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Gallbladder disorder
- Vision blurred
- Anxiety
- Breast cancer
- Cholecystitis chronic (long lasting infection of gallbladder)
- Depression
- Dizziness
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
male:
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Pruritus generalised (generalized itching)
- Renal failure (kidney dysfunction)
- Gallbladder disorder
- Pain
- Chronic kidney disease
- Coronary arterial stent insertion
- Death
What are the common drug interactions of Zaleplon and Vesicare, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Gallbladder disorder
- Pain
- Cholecystitis chronic (long lasting infection of gallbladder)
40-49:
- Breast cancer
- Nausea (feeling of having an urge to vomit)
- Arthralgia (joint pain)
- Blood cholesterol increased
- Blood triglycerides increased
- Candidiasis (candidiasis or thrush is a fungal infection)
- Constipation
- Dysgeusia (disorder of the sense of taste)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hyperlipidaemia (presence of excess lipids in the blood)
50-59:
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Dizziness
- Gallbladder disorder
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Pain
- Vision blurred
- Blindness transient (sudden loss of vision)
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Death
60+:
- Anxiety
- Depression
- Nephrogenic anaemia (anaemia due to kidney disease)
- Oesophageal obstruction (blockage of oesophagus)
- Pneumonia
- Pruritus generalised (generalized itching)
- Renal failure (kidney dysfunction)
- Surgery
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Viral infection
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 28.57%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 17.86%
- Sleep Disorder: 4 people, 14.29%
- Premenstrual Syndrome: 4 people, 14.29%
- Birth Control: 4 people, 14.29%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 10.71%
- Stress And Anxiety: 2 people, 7.14%
- Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 7.14%
- Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 7.14%
- Migraine (headache): 2 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Zaleplon and Vesicare?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Zaleplon and Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zaleplon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zaleplon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vesicare and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on zaleplon and solifenacin succinate (the active ingredients of Zaleplon and Vesicare, respectively), and Zaleplon and Vesicare (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fatigue in Folvite, how severe and when it was recovered? - 4 seconds ago
- Hair Loss in Hydrocodone Bitartrate And Acetaminophen, how severe and when it was recovered? - 5 seconds ago
- Could Fasenra cause Blood Pressure Abnormal? - 6 seconds ago
- Estradiol And Norgestimate vs. Micronor, side effect and effectiveness comparison - 29 seconds ago
- Tendon Pain and drugs of ingredients of acetaminophen - 36 seconds ago
- Could Maxair cause Gallstones? - 38 seconds ago
- Glucotrol and Blood Glucose Decreased for Women aged 60+ - 45 seconds ago
- Robaxisal vs. Norflex, side effect and effectiveness comparison - 48 seconds ago
- Divalproex Sodium vs. Keppra, side effect and effectiveness comparison - 53 seconds ago
- Drug interactions of Dexlansoprazole and Zanaflex - 58 seconds ago